Delivery of antigens to the MHC class I pathway using bacterial toxins

Human Immunology

Volumn 54, Issue 2, 1997, Pages 129-136

  Goletz, T J ^a   Klimpel, K R ^b,c   Leppla, S H ^b   Keith, J M ^b   Berzofsky, J A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c Biopraxis Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ANTHRAX TOXIN; BACTERIAL TOXIN; DIPHTHERIA TOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERTUSSIS TOXIN; PROTEASOME; PSEUDOMONAS EXOTOXIN;

ANTIGEN PRESENTATION; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW;

ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; DIPHTHERIA TOXIN; EXOTOXINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PEPTIDE HYDROLASES; VIRULENCE FACTORS, BORDETELLA;

EID: 0030852483     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00081-5     Document Type: Review

References (90)

1. Yague J, White J, Coleclough C, Kappler J, Palmer E, Marrack P: The T cell receptor: the alpha and beta chains define idiotype, and antigen and MHC specificity. Cell 42:81, 1985.
2. Dembic Z, Haas W, Weiss S, McCubrey J, Kiefer H, Von Boehmer H, Steinmetz M: Transfer of specificity by murine alpha and beta T-cell receptor genes. Nature 320: 232, 1986.
3. Saito T, Weiss A, Miller J, Norcross MA, Germain RN: Specific antigen-Ia activation of transfected human T cells expressing murine Ti d/b-human T3 receptor complexes. Nature 325:125, 1987.
4. Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER: The binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317:359, 1985.
5. Buus S, Sette A, Colon SM, Jenis DM, Grey HM: Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 47:1071, 1986.
6. Townsend ARM, Gotch FM, Davey J: Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42:457, 1985.
7. Moore MW, Carbone FR, Bevan MJ: Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777, 1988.
8. Yewdell JW, Bennink JR, Hosaka Y: Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239:637, 1988.
9. Ziegler K, Unanue ER: Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol 127: 1869, 1981.
10. Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ: Differences in antigen presentation to MHC class I and class II-restricted influenza virus specific cytolytic T lymphocyte clones. J Exp Med 163:903, 1986.
11. Bjorkman PJ, Parham P: Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 59:253, 1990.
12. Kaufman JF, Auffray C, Korman AJ, Shackelford DA, Strominger J: The class II molecules of the human and murine major histocompatibility complex. Cell 36:1, 1984.
13. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen HLA-A2. Nature 329:506, 1987.
14. b molecule. Nature 348:213, 1990.
15. Kelly A, Powis SH, Kerr L-A, Mockridge I, Elliott T, Bastin J, Uchanska-Ziegler B, Ziegler A, Trowsdale J, Townsend A: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355:641, 1992.
16. Attaya M, Jameson S, Martinez CK, Hermel E, Aldrich C, Forman J, Fischer Lindahl K, Bevan MJ, Monaco JJ: Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355:647, 1992.
17. Spies T, DeMars R: Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351:323, 1991.
18. Brown MG, Driscoll J, Monaco JJ: Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353:355, 1991.
19. Martinez CK, Monaco JJ: Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 353:664, 1991.
20. Kelly A, Powis SH, Glynne R, Radley E, Beck S, Trowsdale J: Second proteasome-related gene in the human MHC class II region. Nature 353:667, 1991.
21. Glynne R, Powis SH, Beck S, Kelly A, Kerr L-A, Trowsdale J: A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:357, 1991.
22. Tanaka K: Molecular biology of proteasomes. Mol Biol Rep 21:21, 1995.
23. Ciechanover A: The ubiquitin-proteasome proteolytic pathway. Cell 79:13, 1994.
24. Michalek MT, Grant EP, Gramm C, Goldberg AL, Rock KL: A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 363:552, 1993.
25. Fehling HJ, Swat W, Laplace C, Kühn R, Rajewsky K, Müller U, Von Boehmer H: MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265:1234, 1994.
26. Gaczynska M, Rock KL, Goldberg AL: γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264, 1993.
27. Boes B, Hengel H, Ruppert T, Multhaup G, Koszinowski UH, Kloetzel PM: Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J Exp Med 179:901, 1994.
28. Jacobson S, Sekaly RP, Jacobson CL, McFarland HF, Long EO: HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol 63: 1756, 1989.
29. Bikoff EK: Class II-restricted IgG2ab-specific T cells recognize a signal-minus form of the V-CH3b antigen. Eur J Immunol 21:1411, 1991.
30. Malnati MS, Marti M, LaVaute T, Jaraquemada D, Biddison W, DeMars R, Long EO: Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 357:702, 1992.
31. Seglen PO, Bohley P: Autophagy and other vacuolar protein degradation mechanisms. Experientia 48:158, 1992.
32. Carbone FR, Bevan MJ: Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 171:377, 1990.
33. Carter VC, Schaffer PA, Tevethia SS: The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity. J Immunol 126:1655, 1981.
34. Kaufmann SH: CD8+ T lymphocytes in intracellular microbial infections. Immunol Today 9:168, 1988.
35. Kovacsovics-Bankowski M, Rock KL: A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243, 1995.
36. Riddell SR, Rabin M, Geballe AP, Britt WJ, Greenberg PD: Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J Immunol 146:2795, 1991.
37. Takahashi H, Takeshita T, Morein B, Putney SD, Germain RN, Berzofsky JA: Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344:873, 1990.
38. Newman MJ, Wu JY, Gardner BH, Munroe KJ, Leombruno D, Recchia J, Kensil CR, Coughlin RT: Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J Immunol 148:2357, 1992.
39. b is sequence dependent. Eur J Immunol 22:1603, 1992.
40. Collins DS, Findlay K, Harding CV: Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J Immunol 148: 3336, 1992.
41. Sandvig K, Olsnes S: Entry of the toxic proteins abrin, modecin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles. J Biol Chem 257:7504, 1982.
42. Marnell MH, Shia SP, Stookey M, Draper RK: Evidence for penetration of diphtheria toxin to the cytosol through a prelysosomal membrane. Infect Immun 44:145, 1984.
43. Yewdell JW, Bennink JR: The binary logic of antigen processing and presentation to T cells. Cell 62:203, 1990.
44. Prior TI, FitzGerald DJ, Pastan I: Barnase toxin: a new chimeric toxin composed of Pseudomonas exotoxin A and barnase. Cell 64:1017, 191.
45. Stenmark H, Moskaug JO, Madshus IH, Sandvig K, Olsnes S: Peptides fused to the amino-terminal end of diphtheria toxin are translocated to the cytosol. J Cell Biol 113:1025, 1991.
46. Drazin R, Kandel J, Collier RJ: Structure and activity of diphtheria toxin II. Attack by trypsin at a specific site within the intact toxin molecule. J Biol Chem 246:1504, 1971.
47. Stenmark H, Olsnes S, Sandvig K: Requirement of specific receptors for efficient translocation of diphtheria toxin A fragment across the plasma membrane. J Biol Chem 263:13449, 1988.
48. O'Keefe DO, Cabiaux V, Choe S, Eisenberg D, Collier RJ: pH-dependent insertion of proteins into membranes: B-chain mutation of diphtheria toxin that inhibits membrane translocation, Glu-349-Lys. Proc Natl Acad Sci USA 89:6202, 1992.
49. Sandvig K, Olsnes S: Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule. J Biol Chem 256:9068, 1981.
50. Blewitt MG, Chung LA, London E: Effect of pH on the conformation of diphtheria toxin and its implications for membrane penetration. Biochemistry 24:5458, 1985.
51. Cabiaux V, Brasseur R, Wattiez R, Falmagne P, Ruysschaert JM, Goormaghtigh E: Secondary structure of diphtheria toxin and its fragments interacting with acidic liposomes studied by polarized infrared spectroscopy. J Biol Chem 264:4928, 1989.
52. Madshus IH, Stenmark H, Sandvig K, Olsnes S: Entry of diphtheria toxin-protein A chimeras into cells. J Biol Chem 266:17446, 1991.
53. Madshus IH, Olsnes S, Stenmark H: Membrane translocation of diphtheria toxin carrying passenger protein domains. Infect Immun 60:3296, 1992.
54. Barbieri JT, Collier RJ: Expression of a mutant, full-length form of diphtheria toxin in Escherichia coli. Infect Immun 55:1647, 1987.
55. Ladant D, Glaser P, Ullmann A: Insertional mutagenesis of Bordetella pertussis adenylate cyclase. J Biol Chem 267: 2244, 1992.
56. Carbonetti N, Tishon A, Oldstone M, Rappuoli R: Use of pertussis toxin vaccine molecule PT19K/129G to deliver peptide epitopes for stimulation of a cytotoxic T lymphocyte response. Abstr Annu Meet Am Soc Microbiol 95: 295, 1995 [Abstract].
57. Sebo P, Fayolle C, d'Andria O, Ladant D, Leclerc C, Ullmann A: Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Infect Immun 63:3851, 1995.
58. Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C: In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. J Immunol 156:4697, 1996.
59. Carbonetti N, Chen C, Irish T, O'Connell C: Development of pertussis and cholera toxins as cytotoxic T lymphocyte vaccine vector molecules. Abstr Annu Meet Am Soc Microbiol 96:277, 1996 [Abstract].
60. Ogata M, Chaudhary VK, Pastan I, FitzGerald DJ: Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol. J Biol Chem 265: 20678, 1990.
61. Donnelly JJ, Ulmer JB, Hawe LA, Friedman A, Shi XP, Leander KR, Shiver JW, Oliff AI, Martinez D, Montgomery D: Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin. Proc Natl Acad Sci USA 90:3530, 1993.
62. Gotch FM, Rothbard J, Howland K, Townsend ARM, McMichael AJ: Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326:881, 1987.
63. Jinno J, Ogata M, Chaudhary VK, Willingham MC, Adhya S, FitzGerald D, Pastan I: Domain II mutants of Pseudomonas exotoxin deficient in translocation. J Biol Chem 264:15953, 1989.
64. Ulmer JB, Donnelly JJ, Liu MA: Presentation of an exogenous antigen by major histocompatibility complex class I molecules. Eur J Immunol 24:1590, 1994.
65. Seetharam S, Chaudhary VK, FitzGerald D, Pastan I: Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J Biol Chem 266: 17376, 1991.
66. Chaudhary VK, Jinno Y, FitzGerald D, Pastan I: Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc Natl Acad Sci USA 87:308, 1997.
67. Lewis MJ, Pelham HR: A human homologue of yeast HDEL receptor. Nature 348:162-163, 1990.
68. Tse DB, Pernis B: Spontaneous internalization of class I major histocompatibility complex molecules in T lymphoid cells. J Exp Med 159:193, 1984.
69. Reid PA, Watts C: Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature 346:655, 1990.
70. Vega MA, Strominger JL: Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. Proc Natl Acad Sci USA 86:2688, 1989.
71. Hochman JH, Jiang H, Matyus L, Edidin M, Pernis B: Endocytosis and dissociation of class I MHC molecules labeled with fluorescent beta-2 microglobulin. J Immunol 146:1862, 1989.
72. Smith H, Keppie J: Observations on experimental anthrax: demonstration of a specific lethal factor produced in vivo by Bacillus anthracis. Nature 173:869, 1954.
73. Smith H, Stanley JL: Purification of the third factor of anthrax toxin. J Gen Microbiol 29:517, 1962.
74. Smith H, Stoner HB: Anthrax toxic complex. Fed Proc 26:1554, 1967.
75. Leppla S: Anthrax toxins. In Moss J, Iglewski B, Vaughan M, Tu A (eds): Bacterial Toxins and Virulence Factors in Disease. Handbook of Natural Toxins, Vol 8. New York, Marcel Dekker, Inc., 1995:543.
76. Friedlander AM: Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem 261:7123, 1986.
77. Leppla SH: Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 79:3162, 1982.
78. Leppla SH, Klimpel KR, Arora N: Anthrax toxin mechanisms of receptor binding and internalization. In Kado CI, Crosa JH (eds): Molecular Mechanisms of Bacterial Virulence. Amsterdam, Kluwer Academic, 1994:127.
79. Klimpel KR, Molloy SS, Thomas G, Leppla SH: Anthrax toxin protective antigen is activated by a cell-surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci USA 89:10277, 1992.
80. Novak JM, Stein MP, Little SF, Leppla SH, Friedlander AM: Functional characterization of protease-treated Bacillus anthracis protective antigen. J Biol Chem 267:17186, 1992.
81. Blaustein RO, Koehler TM, Collier RJ, Finkelstein A: Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers. Proc Natl Acad Sci USA 86:2209, 1989.
82. Milne JC, Collier RJ: pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol Microbiol 10:647, 1993.
83. Milne JC, Furlong D, Hanna PC, Wall JS, Collier RJ: Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem 269:20607, 1994.
84. Milne JC, Blanke SR, Hanna PC, Collier RJ: Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus. Mol Microbiol 15:661, 1995.
85. Arora N, Klimpel KR, Singh Y, Leppla SH: Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells. J Biol Chem 267:15542, 1992.
86. Arora N, Leppla SH: Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells. Infect Immun 62:4955, 1994.
87. Arora N, Williamson LC, Leppla SH, Halpern JL: Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in nonneuronal cells. J Biol Chem 269:26165, 1994.
88. Arora N, Leppla SH: Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J Biol Chem 268:3334, 1993.
89. Ballard JD, Collier RJ, Starnbach MN: Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc Natl Acad Sci USA 93:12531, 1996.
90. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL: Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726, 1995.